Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 29001-29050 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06331338
Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
NA
Recruiting
130 participants
Started: Feb 14, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06322667
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
N/A
Recruiting
5,000 participants
Started: Feb 14, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
3 locations
NCT06249880
Pediatric Normative Markerless Movement Analysis
N/A
Recruiting
40 participants
Started: Feb 14, 2024 · Completed: Feb 14, 2025
2 conditions
1 sponsor
1 location
NCT06254534
Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy
NA
Recruiting
100 participants
Started: Feb 14, 2024 · Completed: Jul 31, 2025
4 conditions
1 sponsor
1 location
NCT06262295
A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP
N/A
Recruiting
600 participants
Started: Feb 14, 2024 · Completed: Sep 14, 2028
1 condition
2 sponsors
1 location
NCT05783323
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
PHASE2
Recruiting
13 participants
Started: Feb 14, 2024 · Completed: Oct 1, 2027
4 conditions
2 sponsors
5 locations
NCT06981039
Comparison of Patella Plating Versus Tension Band Wiring for the Treatment of Unstable Patellar Fractures
NA
Recruiting
60 participants
Started: Feb 14, 2024 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06133140
Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial
N/A
Recruiting
856 participants
Started: Feb 14, 2024 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT06165016
Far Red Light to Improve Functioning in PAD
NA
Recruiting
32 participants
Started: Feb 14, 2024 · Completed: Jun 1, 2027
4 conditions
1 sponsor
2 locations
NCT06255743
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE
NA
Recruiting
50 participants
Started: Feb 14, 2024 · Completed: Feb 14, 2025
1 condition
1 sponsor
1 location
NCT06226129
Gadopiclenol in Contrast Enhanced MRI of the Prostate
PHASE4
Recruiting
150 participants
Started: Feb 14, 2024 · Completed: Feb 1, 2028
1 condition
2 sponsors
1 location
NCT06248333
Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
NA
Recruiting
33 participants
Started: Feb 14, 2024 · Completed: Jun 30, 2026
1 condition
5 sponsors
1 location
NCT05635344
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
PHASE2
Recruiting
20 participants
Started: Feb 14, 2024 · Completed: Aug 1, 2026
3 conditions
2 sponsors
1 location
NCT06651944
Invisalign® System with Mandibular Advancement
NA
Recruiting
36 participants
Started: Feb 14, 2024 · Completed: Dec 31, 2026
4 conditions
1 sponsor
3 locations
NCT06254885
Insertion Protocol of Convergent Transmucosal Design Implants
NA
Recruiting
25 participants
Started: Feb 14, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05723276
Psilocybin in Functional Neurological Disorder
NA
Recruiting
24 participants
Started: Feb 14, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT04941599
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
PHASE2
Recruiting
72 participants
Started: Feb 14, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06214039
Virtual Reality Exposure for Public Speaking Anxiety
NA
Recruiting
80 participants
Started: Feb 14, 2024 · Completed: May 31, 2026
1 condition
4 sponsors
1 location
NCT06147973
An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
NA
Recruiting
148 participants
Started: Feb 14, 2024 · Completed: Jan 1, 2028
1 condition
1 sponsor
1 location
NCT06178276
Investigation of Neurophysiological Functioning During Oral Comprehension Task
N/A
Recruiting
70 participants
Started: Feb 14, 2024 · Completed: Feb 28, 2026
3 conditions
3 sponsors
1 location
NCT06014515
Single-tracer Multiparametric PET Imaging
EARLY_PHASE1
Recruiting
60 participants
Started: Feb 14, 2024 · Completed: Aug 31, 2033
2 conditions
2 sponsors
1 location
NCT06270823
Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial
NA
Recruiting
562 participants
Started: Feb 14, 2024 · Completed: Feb 14, 2025
1 condition
2 sponsors
1 location
NCT05979389
Bicalutamide Therapy in Young Women With NAFLD and PCOS
PHASE1
Recruiting
50 participants
Started: Feb 14, 2024 · Completed: Aug 31, 2028
2 conditions
2 sponsors
1 location
NCT06380738
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
N/A
Recruiting
250 participants
Started: Feb 14, 2024 · Completed: Jan 31, 2027
1 condition
2 sponsors
34 locations
NCT06295614
Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease
NA
Recruiting
6 participants
Started: Feb 14, 2024 · Completed: Apr 1, 2029
1 condition
1 sponsor
1 location
NCT05389410
PICO 7 vs PICO 14 in Revision Hip and Revision Knee Surgery.
NA
Recruiting
164 participants
Started: Feb 14, 2024 · Completed: Feb 14, 2027
1 condition
1 sponsor
1 location
NCT05990738
DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy
PHASE1
Recruiting
90 participants
Started: Feb 14, 2024 · Completed: Jul 30, 2027
1 condition
1 sponsor
16 locations
NCT06414928
Prognostic Model Heart Failure
N/A
Recruiting
1,000 participants
Started: Feb 14, 2024 · Completed: Jun 14, 2026
1 condition
1 sponsor
1 location
NCT04881240
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
PHASE1
Recruiting
60 participants
Started: Feb 14, 2024 · Completed: Jul 1, 2028
3 conditions
1 sponsor
1 location
NCT06235970
Cognitive Enhancement Through Model-based and Individualized Neurostimulation
NA
Recruiting
72 participants
Started: Feb 13, 2024 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06311500
Sleep Health Enhancement in Midlife Adults
PHASE1/PHASE2
Recruiting
40 participants
Started: Feb 13, 2024 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06112171
Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions
NA
Recruiting
120 participants
Started: Feb 13, 2024 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT06078553
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
N/A
Recruiting
100 participants
Started: Feb 13, 2024 · Completed: Jun 30, 2027
1 condition
1 sponsor
11 locations
NCT05850247
Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2
PHASE2
Recruiting
20 participants
Started: Feb 13, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06096701
Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women
N/A
Recruiting
540 participants
Started: Feb 13, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT06106035
The Effect of a Low-fat Vegan Dietary Intervention on Intracellular Lipid, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes
NA
Recruiting
20 participants
Started: Feb 13, 2024 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06188793
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
NA
Recruiting
40 participants
Started: Feb 13, 2024 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05386394
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
PHASE2
Recruiting
180 participants
Started: Feb 13, 2024 · Completed: Feb 1, 2028
3 conditions
2 sponsors
3 locations
NCT06270238
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients
NA
Recruiting
120 participants
Started: Feb 13, 2024 · Completed: Sep 30, 2025
1 condition
9 sponsors
1 location
NCT06321133
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
NA
Recruiting
50 participants
Started: Feb 13, 2024 · Completed: Dec 31, 2028
1 condition
4 sponsors
4 locations
NCT06538948
Direct Measurement of Ingestive Behaviour in Relation to Sex Differences and Gastrointestinal Hormone Levels in Patients After Metabolic and Bariatric Surgery
N/A
Recruiting
420 participants
Started: Feb 13, 2024 · Completed: Aug 31, 2027
1 condition
3 sponsors
2 locations
NCT06281652
Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline
NA
Recruiting
80 participants
Started: Feb 13, 2024 · Completed: Feb 13, 2025
2 conditions
1 sponsor
1 location
NCT06033196
Tocilizumab in Lung Transplantation
PHASE2
Recruiting
350 participants
Started: Feb 13, 2024 · Completed: Jan 8, 2029
1 condition
1 sponsor
14 locations
NCT06807736
PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.
N/A
Recruiting
1,800 participants
Started: Feb 13, 2024 · Completed: Mar 31, 2026
2 conditions
3 sponsors
1 location
NCT06506474
Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis
N/A
Recruiting
3,000 participants
Started: Feb 13, 2024 · Completed: Jun 30, 2027
1 condition
5 sponsors
15 locations
NCT06040099
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
PHASE2
Recruiting
100 participants
Started: Feb 13, 2024 · Completed: Oct 23, 2026
1 condition
1 sponsor
25 locations
NCT06279689
Echography Study_Anthropometric Measurements
NA
Recruiting
90 participants
Started: Feb 13, 2024 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06234098
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
PHASE1/PHASE2
Recruiting
85 participants
Started: Feb 13, 2024 · Completed: Jan 31, 2027
1 condition
2 sponsors
7 locations
NCT06233071
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
PHASE1
Recruiting
32 participants
Started: Feb 13, 2024 · Completed: May 2, 2024
1 condition
1 sponsor
1 location
NCT06486688
Centralized Virtual SBIRT for Pediatric Primary Care
NA
Recruiting
22,320 participants
Started: Feb 13, 2024 · Completed: Aug 31, 2027
4 conditions
1 sponsor
1 location
Previous
1
More pages
578
579
580
581
582
583
584
More pages
1333
Next